Pharming Group (NASDAQ:PHAR - Get Free Report) rose 6.3% during trading on Tuesday . The company traded as high as $8.26 and last traded at $8.47. Approximately 8,763 shares changed hands during mid-day trading, an increase of 45% from the average daily volume of 6,025 shares. The stock had previously closed at $7.96.
Wall Street Analyst Weigh In
PHAR has been the topic of a number of recent analyst reports. Jefferies Financial Group initiated coverage on shares of Pharming Group in a research report on Monday, December 9th. They issued a "buy" rating and a $14.00 target price on the stock. Oppenheimer increased their price target on shares of Pharming Group from $30.00 to $39.00 and gave the stock an "outperform" rating in a research report on Friday. Finally, HC Wainwright reissued a "buy" rating and set a $37.00 price target on shares of Pharming Group in a research report on Friday.
Read Our Latest Stock Analysis on Pharming Group
Pharming Group Trading Up 0.3 %
The company's fifty day moving average is $8.99 and its two-hundred day moving average is $8.58. The stock has a market cap of $596.63 million, a price-to-earnings ratio of -33.73 and a beta of -0.10. The company has a quick ratio of 2.76, a current ratio of 3.53 and a debt-to-equity ratio of 0.41.
Pharming Group (NASDAQ:PHAR - Get Free Report) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.02). The company had revenue of $92.70 million during the quarter, compared to analysts' expectations of $76.67 million. Pharming Group had a negative net margin of 6.09% and a negative return on equity of 7.65%. On average, research analysts predict that Pharming Group will post -0.2 EPS for the current fiscal year.
Hedge Funds Weigh In On Pharming Group
An institutional investor recently raised its position in Pharming Group stock. Silverberg Bernstein Capital Management LLC increased its stake in shares of Pharming Group (NASDAQ:PHAR - Free Report) by 16.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 47,997 shares of the company's stock after purchasing an additional 6,887 shares during the quarter. Silverberg Bernstein Capital Management LLC owned 0.07% of Pharming Group worth $483,000 as of its most recent SEC filing. 0.03% of the stock is currently owned by hedge funds and other institutional investors.
Pharming Group Company Profile
(
Get Free Report)
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Featured Stories
Before you consider Pharming Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharming Group wasn't on the list.
While Pharming Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
